SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-24-181693
Filing Date
2024-07-19
Accepted
2024-07-19 16:54:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-1 d852087ds1.htm S-1 177710
2 EX-5.1 d852087dex51.htm EX-5.1 9911
3 EX-23.1 d852087dex231.htm EX-23.1 1668
4 EX-FILING FEES d852087dexfilingfees.htm EX-FILING FEES 14946
5 GRAPHIC g852087g0719015534093.jpg GRAPHIC 2394
6 GRAPHIC g852087g11a01.jpg GRAPHIC 36739
  Complete submission text file 0001193125-24-181693.txt   259593
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-280919 | Film No.: 241128324
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)